- Home
- EDU vs LNTH Comparison
EDU vs LNTH Comparison
Compare EDU & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDU
- LNTH
- Stock Information
- Founded
- EDU 1993
- LNTH 1956
- Country
- EDU China
- LNTH United States
- Employees
- EDU N/A
- LNTH N/A
- Industry
- EDU Other Consumer Services
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- EDU Real Estate
- LNTH Health Care
- Exchange
- EDU Nasdaq
- LNTH Nasdaq
- Market Cap
- EDU 7.3B
- LNTH 7.5B
- IPO Year
- EDU 2006
- LNTH 2015
- Fundamental
- Price
- EDU $47.39
- LNTH $75.56
- Analyst Decision
- EDU Hold
- LNTH Strong Buy
- Analyst Count
- EDU 4
- LNTH 5
- Target Price
- EDU $48.50
- LNTH $133.80
- AVG Volume (30 Days)
- EDU 758.7K
- LNTH 1.5M
- Earning Date
- EDU 04-23-2025
- LNTH 05-07-2025
- Dividend Yield
- EDU 1.23%
- LNTH N/A
- EPS Growth
- EDU 27.46
- LNTH N/A
- EPS
- EDU 2.29
- LNTH 3.53
- Revenue
- EDU $4,793,786,000.00
- LNTH $1,536,699,000.00
- Revenue This Year
- EDU $13.48
- LNTH $4.63
- Revenue Next Year
- EDU $12.89
- LNTH $9.35
- P/E Ratio
- EDU $20.67
- LNTH $21.40
- Revenue Growth
- EDU 18.73
- LNTH 12.53
- 52 Week Low
- EDU $40.66
- LNTH $73.11
- 52 Week High
- EDU $87.26
- LNTH $126.89
- Technical
- Relative Strength Index (RSI)
- EDU 48.73
- LNTH 32.65
- Support Level
- EDU $46.64
- LNTH $73.75
- Resistance Level
- EDU $49.72
- LNTH $76.34
- Average True Range (ATR)
- EDU 0.98
- LNTH 2.50
- MACD
- EDU -0.12
- LNTH -0.09
- Stochastic Oscillator
- EDU 37.00
- LNTH 23.36
About EDU New Oriental Education & Technology Group Inc.
New Oriental is a prominent private education provider in China, offering a wide array of educational services. These include overseas test preparation, consulting services, high school academic tutoring, nonacademic tutoring, and intelligent learning systems and devices. Additionally, the company holds a 57% ownership stake in East Buy, a leading player in the livestreaming e-commerce market.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.